EUVIMEDEUVIMED entdecken
Crossref

SRS120 - The impact of trauma and orthopaedic national institute of health research trials

Carlo Ross, Callum Craig, Lynn Hutchings, Xavier Griffin, Matt Costa, Caroline Hing

British Journal of Surgery · 27.03.2026 · 113 (Supplement_2)

DOI: 10.1093/bjs/znag018.116 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Surgery, online erschienen am 27.03.2026. Verfasst von Carlo Ross und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

The United Kingdom’s National Institute for Health and Care Research (NIHR) has invested heavily in orthopaedic trauma research over the past two decades. We aimed to synthesise NIHR-funded trauma trials, describing their volume, design, recruitment, academic reach, economic evaluation, and equity reporting.

Methods

We conducted a scoping review using Arksey and O’Malley and Joanna Briggs Institute methodology. Clinical Trials Units delivering NIHR trauma studies were contacted, and searches undertaken in Ovid MEDLINE®, Embase, PubMed, and NIHR trial websites (2008–2025). Eligible studies were NIHR-funded UK orthopaedic trauma trials. Data were extracted on study dates, recruitment, demographics, trial design, anatomical focus, publication venue, academic impact (Altmetric/PlumX), and economic or equity outcomes.

Results

Fifty-seven NIHR trauma trials were identified, including 22 published studies. Across completed trials, 45 880 patients were screened and 17 623 randomised, a 38.4% conversion rate. Participants ranged from children to older adults; only two trials reported ethnicity and none reported outcomes by deprivation. Most trials focused on lower-limb trauma (68%). Collaborative authorship rose over time (median 61 authors). Visibility was highest for trials published in The BMJ, The Lancet, and The New England Journal of Medicine. Six trials reported economic evaluations; four showed NHS savings (£60–£644 per patient), while two had mixed or unfavourable results.

Conclusions

NIHR trauma trials have delivered large-scale, practice-informing studies with high impact and growing collaboration. However, economic evaluation is inconsistent, upper-limb and paediatric trauma under-represented, and equity reporting limited. Future trials should integrate standardised economic and equity analyses to maximise policy relevance.

Zitieren

APA

Ross, C., Craig, C., Hutchings, L., Griffin, X., Costa, M., & Hing, C. (2026). SRS120 - The impact of trauma and orthopaedic national institute of health research trials. British Journal of Surgery, 113(Supplement_2). https://doi.org/10.1093/bjs/znag018.116

Vancouver

Ross C, Craig C, Hutchings L, Griffin X, Costa M, Hing C. SRS120 - The impact of trauma and orthopaedic national institute of health research trials. British Journal of Surgery. 2026;113(Supplement_2). doi:10.1093/bjs/znag018.116

BibTeX
@article{Ross2026,
  author = {Ross, Carlo and Craig, Callum and Hutchings, Lynn and Griffin, Xavier and Costa, Matt and Hing, Caroline},
  title = {SRS120 - The impact of trauma and orthopaedic national institute of health research trials},
  journal = {British Journal of Surgery},
  year = {2026},
  volume = {113},
  number = {Supplement_2},
  doi = {10.1093/bjs/znag018.116}
}
Kostenlos starten →